Novo Nordisk Clinical Trial Call Center

Boston, Massachusetts 02118

0 studies enrolling now · 3 studies all time

What they study most

Acquired Bleeding Disorder, Congenital Bleeding Disorder, Congenital FXIII Deficiency, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors, Trauma

Studies at this site

• Efficacy and Safety of NNC 0078-0000-0007 in Patients With Congenital Haemophilia and Inhibitors — Completed
• Safety and Efficacy of Monthly Replacement Therapy With Recombinant Factor XIII (rFXIII) in Paediatric Subjects With Congenital Factor XIII A-subunit Deficiency — Completed
• Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to Trauma — Withdrawn before enrolling